Method of electrochemically modifying surface of electrode using dopamine-hyaluronic acid conjugates

Patent metadata

Field	Value
Publication number	US-10696753-B2
Application number	US-201715783553-A
Country	US
Kind code	B2
Filing date	Oct 13, 2017
Priority date	Oct 14, 2016
Publication date	Jun 30, 2020
Grant date	Jun 30, 2020

Abstract

Provided are a method of electrically modifying an electrode surface with dopamine-hyaluronic acid conjugates and technologies to suppress adsorption of harmful biomaterials and organisms by imparting anti-fouling to the electrode surface using the same and to maintain electrical properties of the electrode. More specifically, provided is a technology of coating an electrode surface via a dopamine functional group by electrochemically oxidizing dopamine-conjugated biocompatible polysaccharide polymers around the electrode. This aims to confirm the capability of suppressing organism adhesion depending on whether or not cells are adsorbed after coating the electrode surface, and to identify that electrochemical performance of the electrode is maintained or a slight increase in electrode resistance is kept, even after the electrode coating. The surface modified electrode according to the present invention can be widely used in the field of biomaterials such as bio-electrodes, bio-sensors and cell supports.

First claim

What is claimed is:

1. A method of electrochemically modifying an electrode surface comprising applying a current to an electrode immersed in a solution comprising a compound represented by the following Formula 1:

wherein the compound has a molecular weight of 35 kDa to 3 MDa, and m/(m+n) is 0.03 to 0.3, and
wherein the surface modification method is carried out by immersing a reference electrode and a counter electrode in the solution to form a three electrode cell and conducting a potentiostatic method.

2. The method according to claim 1 , wherein
the electrode is an ITO electrode or a gold electrode,
the reference electrode is a silver/silver chloride reference electrode, and
the counter electrode is a Pt electrode.

3. The method according to claim 2 , wherein the solution has a concentration of the compound of 1 to 10 mg/mL and a pH of 2 to 7.

4. The method according to claim 3 , wherein the current is applied at a constant potential within a range of 0.6 to 1.6 V for 100 to 600 seconds.

5. The method according to claim 1 , wherein the compound is formed by bonding between dopamine and hyaluronic acid.

Assignees

• Gwangju Inst Science & Tech

Inventors

• Lee Jae Young
• Kim Semin
• Jang Yesul

Classifications

• C08B37/0072 Primary

  Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates · CPC title

• C25D17/10

  Electrodes {, e.g. composition, counter electrode} · CPC title

• C25D21/12

  Process control or regulation (controlling or regulating in general G05) · CPC title

• G01N23/2273

  Measuring photoelectron spectrum, e.g. electron spectroscopy for chemical analysis [ESCA] or X-ray photoelectron spectroscopy [XPS] · CPC title

• C25D9/02 Primary

  with organic materials · CPC title